Down-regulation of Nogo receptor promotes functional recovery by enhancing axonal connectivity after experimental stroke in rats.
The inability of axons in central nervous system (CNS) to regenerate after injury is related partly to multiple endogenous axon growth inhibitors including Nogo receptor (NgR). This study tested the hypothesis that silencing NgR expression by adenovirus-mediated RNA interference (RNAi) (AD-NgR) may permit axonal connectivity after focal cerebral ischemia in rats. Male Sprague-Dawley rats (250-280g, n=97) were assigned into seven groups: sham, MCAO (24h and 2 weeks), MCAO plus AD-NgR (24h and 2 weeks), and MCAO plus AD-HK (control oligonucleotides) (24h and 2 weeks). After cerebral ischemia, NgR mRNA and protein in the cortex and hippocampus were significantly increased at 24h and 2 weeks. However, in AD-NgR treated rats, NgR mRNA and protein were reduced by 40-60% in the cortex and hippocampus at both time points as compared to controls. Although there was no significant difference in the infarct volume between the two groups, the number of midline-crossing fibers projecting to the contralateral red nucleus and corticostriatal fibers in the dorsolateral striatum were increased in AD-NgR injected rats, accompanied by improved behavioral outcomes. Taken together, these results suggest that NgR knockdown may promote CNS axonal regeneration and functional recovery after ischemic cerebral injury.
Wang
Tianzhu
T
Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Wang
Jing
J
Yin
Cheng
C
Liu
Ruen
R
Zhang
John H
JH
Qin
Xinyue
X
D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D001369:Axons / Q000502:physiology*; D001522:Behavior, Animal / Q000502:physiology; D001710:Biotin / Q000031:analogs & derivatives; D015153:Blotting, Western; D002540:Cerebral Cortex / Q000378:metabolism / Q000473:pathology; D003911:Dextrans; D015536:Down-Regulation / Q000502:physiology; D005456:Fluorescent Dyes; D058851:GPI-Linked Proteins; D006624:Hippocampus / Q000378:metabolism / Q000473:pathology; D020244:Infarction, Middle Cerebral Artery / Q000473:pathology; D008297:Male; D009185:Myelin Proteins; D009434:Neural Pathways / Q000502:physiology*; D000070816:Nogo Receptor 1; D011597:Psychomotor Performance / Q000502:physiology; D011712:Pyramidal Tracts / Q000473:pathology / Q000502:physiology; D034622:RNA Interference; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D011956:Receptors, Cell Surface; D018000:Receptors, Peptide / Q000235:genetics / Q000502:physiology*; D020127:Recovery of Function / Q000502:physiology*; D015427:Reperfusion Injury / Q000473:pathology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013238:Stereotaxic Techniques; D020521:Stroke / Q000473:pathology* / Q000503:physiopathology
D003911:Dextrans; D005456:Fluorescent Dyes; D058851:GPI-Linked Proteins; D009185:Myelin Proteins; D000070816:Nogo Receptor 1; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D018000:Receptors, Peptide; C486581:Rtn4r protein, rat; C076397:biotinylated dextran amine; D001710:Biotin